Comparative Benchmarking
In the context of the broader market, NGEN competes directly with industry leaders such as RCKT and CBIO. With a market capitalization of $295.46M, it holds a significant position in the sector. When comparing efficiency, NGEN's gross margin of N/A stands against RCKT's N/A and CBIO's N/A. Such benchmarking helps identify whether NervGen Pharma Corp is trading at a premium or discount relative to its financial performance.
